Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients

Anti-PD1 treatment has improved the survival of metastatic melanoma patients, yet it is unknown which patients benefit from the treatment. In this exploratory study, we aimed to understand the effects of anti-PD1 therapy on the patients’ immune system and discover the characteristics that would resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasanen, Henna, Hernberg, Micaela, Mäkelä, Siru, Brück, Oscar, Juteau, Susanna, Kohtamäki, Laura, Ilander, Mette, Mustjoki, Satu, Kreutzman, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183505/
https://www.ncbi.nlm.nih.gov/pubmed/32036449
http://dx.doi.org/10.1007/s00262-020-02497-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183505/
https://www.ncbi.nlm.nih.gov/pubmed/32036449
http://dx.doi.org/10.1007/s00262-020-02497-9

Ejemplares similares